C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 213/81 (2006.01) A61K 31/4418 (2006.01) A61K 31/4427 (2006.01) A61K 31/4725 (2006.01) A61K 31/506 (2006.01) C07D 401/04 (2006.01) C07D 401/10 (2006.01) C07D 405/04 (2006.01) C07D 417/04 (2006.01)
Patent
CA 2659682
The present disclosure relates to HIF-1.alpha. prolyl hydroxylase inhibitors of Formula I (see formula I) wherein R, R1, R2, R3, R a and I, are as defined in the description, compositions which comprise the HIF-1.alpha. prolyl hydroxylase inhibitors of Formula I and to methods for controlling, inter alia, Peripheral Vascular Disease (PVD), Coronary Artery Disease (CAD), heart failure, ischemia, and anemia using the compounds of Formula I.
L'invention porte sur des inhibiteurs de la HIF-1.alpha. prolyl hydroxylase, sur des compositions renfermant lesdits inhibiteurs de la HIF-1.alpha. prolyl hydroxylase et sur des procédés permettant de maîtriser l'acrosyndrome, la coronaropathie, l'insuffisance cardiaque, l'ischémie et l'anémie.
Boyer Angelique Sun
Edokimov Artem G.
Greis Kenneth Donald
Kawamoto Richard Masaru
Warshakoon Namal Chithranga
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
The Procter & Gamble Company
Warner Chilcott Company Llc
LandOfFree
Prolyl hydroxylase inhibitors and methods of use does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prolyl hydroxylase inhibitors and methods of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prolyl hydroxylase inhibitors and methods of use will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1965075